FTSE falls on Barclays deal

clock

The FTSE 100 is down 14.3 points, or 0.22%, to 6,472.5, as confirmation of a deal between Barclays and ABN Amro has failed to push the index higher.

Barclays is the biggest loser with a fall of 1.87% to 736p, as the bank announced it has agreed terms to buy Dutch rival ABN Amro in an all-share deal worth just over €67bn, while AstraZeneca is down 1.56% to £29.07, as it has agreed to buy US biotech MedImmune for $15.2bn. Centrica is also down 1.16% to 384.75p, closely followed by Royal Bank of Scotland Group which has slipped 1.09% to £20.02, while miner Xstrata is down 0.97% to £27.51, although Shire is limiting losses with a rise of 0.74% to £10.91. However, brewer Scottish & Newcastle is posting the biggest gains with a rise of ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login